Savara (SVRA) Net Cash Flow (2010 - 2026)
Savara (SVRA) reported Net Cash Flow of $5.6 million for Q1 2026, up 25.24% year-over-year from $4.5 million in Q1 2025, and down 67.04% on a QoQ basis from $16.9 million in Q4 2025.
Savara (SVRA) has 17 years of Net Cash Flow data on file, last reported at $5.6 million in Q1 2026.
- Quarterly Net Cash Flow rose 25.24% year-over-year to $5.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.5 million (up 592.81% YoY) and the FY2025 annual result came in at $18.3 million, up 260.05% from the prior year.
- Net Cash Flow retreated to $5.6 million in Q1 2026 per SVRA's latest filing, from $16.9 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $45.2 million in Q1 2022 and bottomed at -$67.9 million in Q4 2022.
- The 5-year median for Net Cash Flow is -$1.1 million (2025), against an average of $308294.1.
- Peak annual rise in Net Cash Flow reached 510.75% in 2022, while the deepest fall reached 538.69% in 2022.
- Tracing SVRA's Net Cash Flow over 5 years: stood at -$67.9 million in 2022, then surged by 98.32% to -$1.1 million in 2023, then slumped by 447.85% to -$6.2 million in 2024, then surged by 371.94% to $16.9 million in 2025, then tumbled by 67.04% to $5.6 million in 2026.
- Per Business Quant, the three latest SVRA Net Cash Flow figures stand at $5.6 million (Q1 2026), $16.9 million (Q4 2025), and -$1.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -152.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 60.68 Mn |
| 10 | Savara | 1.30 Bn | 1.30 Bn | - | 5.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.58 Mn |
| Mar 31, 2026 | 5.58 Mn |
| Dec 31, 2025 | 16.94 Mn |
| Dec 31, 2025 | 16.94 Mn |
| Sep 30, 2025 | -1.09 Mn |
| Sep 30, 2025 | -1.09 Mn |
| Jun 30, 2025 | -1.98 Mn |
| Jun 30, 2025 | -1.98 Mn |
| Mar 31, 2025 | 4.46 Mn |
| Mar 31, 2025 | 4.46 Mn |
| Dec 31, 2024 | -6.23 Mn |
| Dec 31, 2024 | -6.23 Mn |
| Sep 30, 2024 | -2.52 Mn |
| Sep 30, 2024 | -2.52 Mn |
| Jun 30, 2024 | 7.10 Mn |
| Jun 30, 2024 | 7.10 Mn |
| Mar 31, 2024 | -9.80 Mn |
| Mar 31, 2024 | -9.80 Mn |
| Dec 31, 2023 | -1.14 Mn |
| Dec 31, 2023 | -1.14 Mn |
| Sep 30, 2023 | 5.01 Mn |
| Sep 30, 2023 | 5.01 Mn |
| Jun 30, 2023 | -11.17 Mn |
| Jun 30, 2023 | -11.17 Mn |
| Mar 31, 2023 | -18.10 Mn |
| Mar 31, 2023 | -18.10 Mn |
| Dec 31, 2022 | -67.86 Mn |
| Dec 31, 2022 | -67.86 Mn |
| Sep 30, 2022 | 24.83 Mn |
| Sep 30, 2022 | 24.83 Mn |
| Jun 30, 2022 | 15.97 Mn |
| Jun 30, 2022 | 15.97 Mn |
| Mar 31, 2022 | 45.24 Mn |
| Mar 31, 2022 | 45.24 Mn |
| Dec 31, 2021 | -10.63 Mn |
| Dec 31, 2021 | -10.63 Mn |
| Sep 30, 2021 | 4.07 Mn |
| Sep 30, 2021 | 4.07 Mn |
| Jun 30, 2021 | -15.30 Mn |
| Jun 30, 2021 | -15.30 Mn |
| Mar 31, 2021 | 33.13 Mn |
| Mar 31, 2021 | 33.13 Mn |
| Dec 31, 2020 | -12.68 Mn |
| Dec 31, 2020 | -12.68 Mn |
| Sep 30, 2020 | -11.74 Mn |
| Sep 30, 2020 | -11.74 Mn |
| Jun 30, 2020 | 12.66 Mn |
| Jun 30, 2020 | 12.66 Mn |
| Mar 31, 2020 | -15.33 Mn |
| Mar 31, 2020 | -15.33 Mn |
| Dec 31, 2019 | 32.05 Mn |
| Dec 31, 2019 | 32.05 Mn |
| Sep 30, 2019 | 885,000.00 |
| Sep 30, 2019 | 885,000.00 |
| Jun 30, 2019 | -8.77 Mn |
| Jun 30, 2019 | -8.77 Mn |
| Mar 31, 2019 | 1.36 Mn |
| Mar 31, 2019 | 1.36 Mn |
| Dec 31, 2018 | -528,000.00 |
| Dec 31, 2018 | -528,000.00 |
| Sep 30, 2018 | 1.34 Mn |
| Sep 30, 2018 | 1.34 Mn |
| Jun 30, 2018 | 1.50 Mn |
| Jun 30, 2018 | 1.50 Mn |
| Mar 31, 2018 | -10,000.00 |
| Mar 31, 2018 | -10,000.00 |
| Dec 31, 2017 | 2.23 Mn |
| Dec 31, 2017 | 2.23 Mn |
| Sep 30, 2017 | -41.26 Mn |
| Sep 30, 2017 | -41.26 Mn |
| Jun 30, 2017 | 51.09 Mn |
| Jun 30, 2017 | 51.09 Mn |
| Mar 31, 2017 | -3.32 Mn |
| Mar 31, 2017 | -3.32 Mn |
| Dec 31, 2016 | -2.09 Mn |
| Dec 31, 2016 | -2.09 Mn |
| Sep 30, 2016 | 1.45 Mn |
| Sep 30, 2016 | 1.45 Mn |
| Jun 30, 2016 | -3.09 Mn |
| Jun 30, 2016 | -3.09 Mn |
| Mar 31, 2016 | 469,000.00 |
| Mar 31, 2016 | 469,000.00 |
| Dec 31, 2015 | 10.99 Mn |
| Dec 31, 2015 | 10.99 Mn |
| Sep 30, 2015 | 10.99 Mn |
| Sep 30, 2015 | 10.99 Mn |
| Jun 30, 2015 | -6.72 Mn |
| Jun 30, 2015 | -6.72 Mn |
| Mar 31, 2015 | -7.87 Mn |
| Mar 31, 2015 | -7.87 Mn |
| Dec 31, 2014 | 9.83 Mn |
| Dec 31, 2014 | 9.83 Mn |
| Sep 30, 2014 | -386,000.00 |
| Sep 30, 2014 | -386,000.00 |
| Jun 30, 2014 | -3.48 Mn |
| Jun 30, 2014 | -3.48 Mn |
| Mar 31, 2014 | 4.17 Mn |
| Mar 31, 2014 | 4.17 Mn |
| Dec 31, 2013 | -4.55 Mn |
| Dec 31, 2013 | -4.55 Mn |
| Sep 30, 2013 | -14.74 Mn |
| Sep 30, 2013 | -14.74 Mn |
| Jun 30, 2013 | -2.53 Mn |
| Jun 30, 2013 | -2.53 Mn |
| Mar 31, 2013 | -1.09 Mn |
| Mar 31, 2013 | -1.09 Mn |
| Dec 31, 2012 | -3.60 Mn |
| Dec 31, 2012 | -3.60 Mn |
| Sep 30, 2012 | -3.87 Mn |
| Sep 30, 2012 | -3.87 Mn |
| Jun 30, 2012 | -5.10 Mn |
| Jun 30, 2012 | -5.10 Mn |
| Mar 31, 2012 | -8.57 Mn |
| Mar 31, 2012 | -8.57 Mn |
| Dec 31, 2011 | 10.80 Mn |
| Dec 31, 2011 | 10.80 Mn |
| Sep 30, 2011 | -9.18 Mn |
| Sep 30, 2011 | -9.18 Mn |
| Jun 30, 2011 | -4.60 Mn |
| Jun 30, 2011 | -4.60 Mn |
| Mar 31, 2011 | 18.57 Mn |
| Mar 31, 2011 | 18.57 Mn |
| Dec 31, 2010 | -1.35 Mn |
| Dec 31, 2010 | -1.35 Mn |
| Sep 30, 2010 | -1.83 Mn |
| Sep 30, 2010 | -1.83 Mn |